Sep 5, 20264:30 PM4:37 PMePoster presentationsINTESTINAL MICROBIOTA OF PATIENTS WITH SHORT BOWEL SYNDROME BEFORE AND AFTER TREATMENT WITH GLEPAGLUTIDE, A LONG-ACTING GLP-2 ANALOGUEPalle Bekker JEPPESEN
Sep 5, 20265:00 PM5:30 PMScientific SessionEnteroendocrine regulation as the future driver of intestinal failure rehabilitation and parenteral support weaning.Palle Bekker JEPPESEN
Sep 6, 20269:10 AM9:20 AMOral CommunicationLONG-TERM TREATMENT WITH ONCE-WEEKLY APRAGLUTIDE REDUCES PARENTERAL SUPPORT DEPENDENCY AND ENABLES ENTERAL AUTONOMY IN SOME PATIENTS WITH SHORT BOWEL SYNDROME AND INTESTINAL FAILUREPalle Bekker JEPPESEN
Sep 7, 202611:15 AM11:24 AMMain SessionCOLORECTAL CANCER INCIDENCE IN ADULTS WITH SHORT BOWEL SYNDROME AND INTESTINAL FAILURE EVER- OR NEVER-TREATED WITH TEDUGLUTIDE: INTERIM REGISTRY ANALYSIS VERSUS GENERAL POPULATIONPalle Bekker JEPPESEN
Sep 7, 202612:30 PM1:30 PMOnlineSatellite SymposiumProtara Therapeutics: Addressing choline deficiency in intestinal failure: Clinical implications and management strategies for pediatric and adult patients dependent on parenteral supportPalle Bekker JEPPESEN
Sep 7, 202612:46 PM12:57 PMSatellite SymposiumCholine Deficiency in Parenteral Support: Evidence, Assessment, and ManagementPalle Bekker JEPPESEN